Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has updated the study details for Avutometinib (VS-6766) and Defactinib in recurrent low-grade serous ovarian cancer, including new dates and a revision update from v2.14.1 to v2.14.2, while removing previous entries with estimated dates.
    Difference
    2%
    Check dated 2025-02-03T06:21:25.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T20:44:47.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.3%
    Check dated 2025-01-12T17:11:30.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T22:33:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with the locations where the study is taking place.
    Difference
    3%
    Check dated 2024-12-07T14:16:59.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Several key URLs related to ovarian cancer and genetics have been removed, indicating a potential shift in focus or resource availability on the website.
    Difference
    5%
    Check dated 2024-11-23T04:29:18.000Z thumbnail image

Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.